Dr. David R. Drosick, MD

Dr. Drosick practices at Cei Physicians PSC, LLC in Cincinnati, Ohio.

Dr. Drosick's NPI, 1699768499, was assigned on August 26, 2005. Dr. Drosick graduated from West Virginia University School of Medicine in 1985. Dr. Drosick holds Ohio license 35.061089.

Dr. Drosick's primary practice is Cei Physicians PSC, LLC, at 604 Ivy Gtwy, Cincinnati, OH 45245 in Clermont County. The practice phone is (513) 984-5133.

Dr. Drosick's primary practice is Cei Physicians PSC, LLC in Cincinnati, Ohio. Dr. Drosick is also affiliated with Bethesda North Hospital. The medical group on file is NovaCare Rehabilitation. Dmand AI also links Dr. Drosick to 4 more hospitals, 1 group practice or clinic, 1 home health agency, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Drosick practices, 8 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Drosick's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Drosick's licenses on file in 2 states: Ohio and Kentucky.

CMS data shows 58,976 Medicare services from Dr. Drosick across 51 procedure codes in 2024, for 725 Medicare patients. Medicare paid $1,286,527 for them.

CMS counts 725 Medicare patients who saw Dr. Drosick in 2024. The largest group is 65 to 74, with 392 patients. 71% of them have high blood pressure, and 71% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Drosick's median patient age at 71, with 67% women.

In 2024, Dr. Drosick wrote 3,509 Medicare Part D claims for 470 patients. 79% of them were for generic drugs. CMS names the drug for 3,070 of them, across 61 drugs with 11 or more claims each, at $4,857,557 in total drug cost. In 2023, CMS named 2,441 claims across 56 drugs.

Dr. Drosick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Drosick, published from 2013 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Bevacizumab. Dr. Drosick has published most often in JCO Oncol Pract. Dr. Drosick's most frequent co-authors are David M. Waterhouse, MD, Brooke E. Daniel, MD and John D. Hainsworth, MD.

CMS Open Payments shows 153 general payments to Dr. Drosick from 44 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 50% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,185.

Dr. Drosick graduated from West Virginia University School of Medicine in 1985.